Pay-For-Delay Deals Stay Under Wraps In Cephalon Suit
By Richard Vanderford ( March 1, 2011, 8:51 PM EST) -- Cephalon Inc. on Monday lost a bid to force the Federal Trade Commission to release the details of dozens of so-called pay-for-delay agreements that name-brand drugmakers used to keep generic competition off the market....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.